Registered drugs - Additional information

Anti-cancer drugs with market authorization in the USA or in countries of the European Union.
Additional information
The Anticancer Fund considers a drug as registered if:
-           The drug is approved by the European Medicine Agency, by the US Food and Drug Administration or by the                       authority of one of the following countries: Belgium, France, Switzerland and the United Kingdom.
-          The drug is approved for the treatment of at least one type of cancer.